COST INDEX
Tirz yr-one floor $139✓ audSema yr-one floor $119✓ audAbsolute floor · micro $110✓ audFifty 410 prepay ~$133on recHims w/ 12-mo term ~$165on recHenry no-term ~$149on recMochi $79+medon recAltRx promo door ~$89on recRemedy promo door $99→on recShedRx entry ~$199on recZepbound vial $349shelfWegovy self-pay $499shelf
VSCompareGLP1ProvidersYEAR-ONE MATH · LIVE-CHECKOUT AUDITSFind my program →

Checklist · printable · provider evaluation

The provider transparency checklist: twenty items for one honest evaluation session

WORKING TOOLUpdated August 17, 2026
THE SHORT ANSWER

One session, four sections, twenty items — run against any program before money moves. Scoring is binary and unforgiving: items 1, 5, and 20 are instant disqualifiers if failed; more than three total misses means walk. Every item links its full file.

Identity & provenance

  1. Pharmacy named. The program states which pharmacy compounds your medication. Fail = disqualified. (why)
  2. Classification answered. 503A or 503B, stated on request. (why)
  3. License verified. You checked the state board or FDA registry yourself — two minutes.
  4. BUD discipline. Beyond-use dating explained and aligned with shipment size. (why)
  5. Prescriber licensure. Clinicians licensed in your state, stated plainly. Fail = disqualified. (why)

Pricing honesty

  1. All-in number confirmed. Medication, consults, shipping, membership — one figure, in writing. (why)
  2. The dose-proof answer. “If my dose doubles, what happens to my bill?” — answered, saved. (why)
  3. Annualized. You multiplied the honest month by twelve and compared it to the sticker. (why)
  4. Maintenance-dose price known. Not the starter price — the month-twenty price. (why)
  5. Refund terms read for anything prepaid. (why)
  6. Comparison run. The figure sits against the cost index and the audited $139/$119 anchors.

Clinical reality

  1. Real intake. Medical history, contraindication screening (the MTC/MEN2 question present), medication review.
  2. A human reachable. The Tuesday-question test passes: clinical questions get clinical answers this week. (why)
  3. Titration policy sane. Holds honored without penalty; escalation clinical, not calendar. (why)
  4. Side-effect support exists. A protocol, not a shrug. (why)
  5. Outside oversight welcomed. The specialist co-management question meets zero friction. (why)

Exit & records

  1. Cancellation terms in writing — method, notice window, fees. (why)
  2. Records access affirmed — your chart within 30 days. (why)
  3. Signup-day screenshots taken — terms, price, policies, filed. (why)
  4. The disclosure line present. Compounded products described as not FDA-approved, plainly. Fail = disqualified. (why)

Context, always: the audited anchor's own scorecard — passes and posted open items alike — lives on the NexLife file, because a checklist this site won't run on its own benchmark is a brochure. Run it against the anchor ↗

SECOND VISIT?

Stop re-reading tabs — answer three questions and the field sorts itself. No email, no account.

Sort the field for me →